Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia

Published:2022-06-04 Issue:4 Volume:40 Page:577-587
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Kumari Sarita¹²,Ali M. Shadab³^ORCID,Singh Jay¹,Arora Mohit⁴,Verma Deepak¹,Pandey Avanish Kumar¹,Benjamin Mercilena¹,Bakhshi Sameer¹^ORCID,Palanichamy Jayanth Kumar¹^ORCID,Sharma Atul⁵,Singh Inder⁶,Tanwar Pranay¹,Singh Amar Ranjan¹,Pushpam Deepam⁵,Qamar Imteyaz²,Chopra Anita¹^ORCID

Affiliation:

1. Laboratory Oncology Unit, Dr. BRA‐IRCH, All India Institute of Medical Sciences New Delhi India

2. School of Biotechnology Gautam Buddha University Greater Noida Uttar Pradesh India

3. Department of Pulmonary Medicine and Sleep Disorders All India Institute of Medical Sciences, New Delhi New Delhi India

4. Department of Biochemistry All India Institute of Medical Sciences New Delhi India

5. Department of Medical Oncology Dr. BRA‐IRCH, All India Institute of Medical Sciences New Delhi India

6. Department of Neurology All India Institute of Medical Sciences, New Delhi New Delhi India

Funder

Department of Science and Technology, Ministry of Science and Technology, India

The Wellcome Trust DBT India Alliance

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3030

Reference36 articles.

1. New Approaches to the Management of Adult Acute Lymphoblastic Leukemia

2. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL);Bene MC;Leukemia,1995

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetics in the management of hematological malignancies: An overview of alternative technologies for cytogenetic characterization;Current Research in Translational Medicine;2024-09

2. Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children;Journal of Cancer Research and Clinical Oncology;2023-06-14

3. The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols;Diagnostics;2023-04-28

4. Copy Number Alterations in CDKN2A/2B and MTAP Genes Are Associated With Low MEF2C Expression in T-cell Acute Lymphoblastic Leukemia;Cureus;2022-12-03